IREN (NASDAQ:IREN) Stock Lags AI and Bitcoin Rallies as Investors Price a $1.3 Billion Execution Gap

IREN (NASDAQ:IREN) Stock Lags AI and Bitcoin Rallies as Investors Price a $1.3 Billion Execution Gap

NEW YORK, July 14, 2026, 18:08 EDT

IREN Limited closed 1.0% lower at $38.59 on Tuesday even as NVIDIA Corp gained 4.1%, bitcoin was up 4.0% and the Nasdaq Composite added 0.9%. IREN has fallen 10.3% from its July 8 close. The split suggests investors are looking past its AI-and-crypto exposure and pricing the harder part: funding and delivery.

IREN had posted no fresh business release since July 8 and no SEC filing since July 9 by Tuesday evening. Trading volume was 35.1 million shares, about 24% below its 65-day average. This was a quiet repricing, not a company-news shock.

Peers tied to the same mining-to-data-center trade also fell: Core Scientific Inc lost 3.0%, Cipher Digital Inc dropped 1.1% and TeraWulf Inc slid 7.1%. IREN outperformed two of the three but still failed to join the chip and bitcoin rebound. Investors treated the group more like capital-heavy builders than direct bets on the assets they serve.

Tuesday market snapshotPrice or index levelDay move
IREN $38.59-1.0%
NVIDIA $211.80+4.1%
Bitcoin$64,576+4.0%
Nasdaq Composite26,107.01+0.9% AP News
Core Scientific $22.09-3.0%
Cipher Digital $19.87-1.1%
TeraWulf $19.41-7.1%

The sharper valuation question sits inside IREN’s $4.4 billion annualized run-rate revenue target. ARR, a one-year revenue pace, comprises an expected $1.9 billion from Microsoft Corp , $700 million from the NVIDIA contract and $1.8 billion from planned GPU deployments based on company assumptions. IREN had previously said $3.1 billion was under contract, leaving about $1.3 billion, or 30% of the target, outside that contracted figure. That is the execution slice.

At a market value of about $13.8 billion, IREN trades at roughly 3.1 times its full ARR target but 4.4 times contracted ARR. Neither is an earnings multiple, and both ignore debt, capital spending and margins; IREN reported $3.69 billion of convertible notes at March 31. The cheap-looking ratio is only as strong as the denominator.

IREN revenue lensAmountShare of $4.4 billion targetEquity value/ARR
Full company target$4.4 billion100%3.1 times
Stated contracted ARR$3.1 billion70%4.4 times
Outside contracted figure, calculated$1.3 billion30%

NVIDIA’s investment right makes the same point. It can buy as many as 30 million IREN shares at $70, but the rights vest in blocks only as delivery volumes rise to as many as 600,000 NVIDIA GPUs and expire in May 2031. Tuesday’s close was 44.9% below that purchase price, meaning IREN would need to gain 81.4% to reach it; if fully exercised, the right covers shares equal to 8.4% of IREN’s latest reported count. The potential $2.1 billion is conditional capital, not cash today.

IREN has reduced one part of the funding risk. It closed a $3.65 billion GPU facility for the Microsoft contract on June 1 and, with a $1.94 billion customer prepayment, said 96% of $5.81 billion in GPU spending was funded at an average financing cost of 3.31%. Co-CEO Daniel Roberts said the structure “lowers our cost of capital as we scale.” That is the strongest financing proof on the page.

But a separate $1.6 billion purchase from Dell Technologies Inc for Blackwell systems was still being financed when IREN last detailed it; payments are structured after shipment and commissioning is targeted for early 2027. Delays in hardware, financing, power or customer acceptance could push revenue out, while completed funding or faster commissioning could close the discount quickly. Timing matters here.

Share count is another concern. IREN reported 357.4 million shares outstanding at April 30, up 38.5% from June 30, 2025, while July 1 awards covered 9,099,328 restricted stock units for each co-CEO — 18.2 million in total, or 5.1% of the April count before vesting and tax effects. Independent chair David Bartholomew wrote: “These are large awards and we do not shy away from that.” The board sees retention; investors still have to model dilution. SEC

IREN says its Horizon 1–4 sites remain on track for delivery by year-end and that operational capacity is fully contracted, giving investors clear milestones. The next sustained stock move is likely to depend less on daily moves in bitcoin or NVIDIA and more on whether those sites arrive, the Dell financing closes and the $1.3 billion execution slice narrows. The market wants proof.

Leokadia Głogulska

Leokadia Głogulska is a financial and technology journalist at TS2.tech. Her coverage ranges from stocks and artificial intelligence to space technology and developments across global markets. She graduated from Wrocław University of Economics and Business and worked in financial analysis before becoming a business journalist.

US Stock Market Today Updates

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 Strong buy

Alphabet

NASDAQ:GOOGL 92/100 • ★★★★½
#2 Strong buy

Taiwan Semiconductor Manufacturing

NYSE:TSM 89/100 • ★★★★½
#3 Buy

S&P Global

NYSE:SPGI 88/100 • ★★★★
#4 Buy on weakness

Amazon

NASDAQ:AMZN 86/100 • ★★★★
#5 Buy on weakness

Microsoft

NASDAQ:MSFT 84/100 • ★★★★
View full portfolio
Editorial model selection. Not personalised advice.
MARKET CALENDAR

Key Events Today

The catalysts most likely to move markets.

#1

U.S. index futures reopen at 18:00 ET

This is the clearest scheduled U.S.-market price-discovery point today and can transmit weekend news into equity-index futures before Monday's cash session.

#2

New Zealand retail sales at 18:45 ET

The Q2 retail package can move NZD and regional risk sentiment. Spillover to U.S. assets is usually secondary unless the result is unusually large.

#3

No scheduled domestic U.S. data or corporate reports

The absence of U.S. releases, earnings, IPO pricings and split events leaves fewer scheduled catalysts, increasing the relative importance of weekend headlines and positioning at the futures reopen.

View full calendar
Times and estimates may change. Verify before trading.
GE HealthCare Technologies Inc. (NASDAQ:GEHC) sheds $1.7 billion as HCA warning tests order-growth case
Previous Story

GE HealthCare Technologies Inc. (NASDAQ:GEHC) sheds $1.7 billion as HCA warning tests order-growth case

Arbe Robotics (NASDAQ:ARBE) shares surge 27% on defense deal, market cap up $23M
Next Story

Arbe Robotics (NASDAQ:ARBE) shares surge 27% on defense deal, market cap up $23M